期刊文献+

血清EPCA-2与FPSA/TPSA值在前列腺癌诊断的关系 被引量:5

The effects of serum EPCA-2 and FPSA/TPSA values on the diagnosis of prostate cancer
下载PDF
导出
摘要 目的:探讨血清早期前列腺癌抗原-2(Early Prostate Cancer Antigen,EPCA-2)、游离型/总PSA(F/TPSA)在前列腺癌(PCa)诊断中的临床应用价值。方法:用酶联免疫吸附测定法(ELISA)分别对前列腺癌组与良性前列腺增生组患者血清进行检测EPCA-2值、F/TPSA值及PSA值,所得数据的分析和处理采用SPSS17.0统计学软件进行。结果:(1)前列腺癌组PSA水平显著高于BPH组,差异有统计学意义(P<0.01)。(2)前列腺癌组FPSA/TPSA水平比值显著低于BPH组,差异有统计学意义(P<0.01)。(3)前列腺癌组EPCA-2水平为(63.45±23.49)ng/mL,而BPH组EPCA-2水平为(16.60±7.62)ng/mL,较前列腺癌组明显为低,差异具有统计学意义(P<0.01)。(4)诊断能力EPCA-2>FPSA/TPSA>PSA。(5)FPSA/TPSA水平与EPCA-2水平之间无相关关系。(6)若将EPCA-2与FPSA/TPSA比值联合应用预测前列腺癌的特异性为90.00%,敏感性为95.00%。结论:EPCA-2、FPSA/TPSA、PSA三者相比在诊断前列腺癌方面的能力排名为EPCA-2>FPSA/TPSA>PSA,并且EPCA-2与FPSA/TPSA比值之间无相关性。若将EPCA-2与FPSA/TPSA比值联合应用在前列腺癌诊断方面可大大提高诊断率,降低活检率。 Objective:To explore the clinical application value of EPCA-2,F/TPSA in the diagnosis of prostate cancer.Methods:Serum EPCA-2value,F/TPSA value,and PSA value of patients with prostate cancer and benign prostatic hyperplasia were detected by enzyme linked immunosorbent assay,respectively.The data were analyzed and processed by SPSS17.0statistical software.Results:(1)The level of PSA in prostate cancer group was significantly higher than that in BPH group,and the difference was statistically significant(P〈0.01).(2)The level of FPSA/TPSA in Prostate cancer group was significantly lower than that in BPH group,and the difference was statistically significant(P〈0.01).(3)EPCA-2level in prostate cancer group was(63.45±23.49)ng/mL;while it was(16.60±7.62)ng/mL in BPH group.The level in prostate cancer group was significantly higher than that in BPH group,and the difference was statistically significant(P〈0.01).(4)Diagnostic capabilities were:EPCA-2〉FPSA/TPSA〉PSA.(5)There was not any correlation between FPSA/TPSA level and EPCA-2 levels.(6)If EPCA-2value and FPSA/TPSA ratio were combined to diagnose prostate cancer,the specificity was of 90.00%,the sensitivity of 95.00%.Conclusions:Sort diagnostic capabilities are:EPCA-2〉FPSA/TPSA〉PSA.No correlation was existed between EPCA-2value and FPSA/TPSA ratio.The application of both EPCA-2level and FPSA/TPSA ratio in the diagnosis of prostate cancer can greatly improve diagnostic rate of prostate cancer,and reduce biopsy rate.
出处 《黑龙江医药科学》 2014年第4期7-8,共2页 Heilongjiang Medicine and Pharmacy
关键词 前列腺癌 良性前列腺增生 早期前列腺癌抗原-2 前列腺特异抗原 prostate cancer(PCa) benign prostatic hyperplasia(BPH) early prostate cancer antigen-2(EPCA-2) prostate specific antigen
  • 相关文献

参考文献7

二级参考文献26

  • 1张灵,计国义,李晓萌,王伟华,高洪文,潘玉琢,王洪军,桑原正明,赵雪俭.fPSA/tPSA比值优化前列腺癌早期诊断作用的研究[J].中华男科学杂志,2004,10(8):582-585. 被引量:18
  • 2官琳妹,李士军.测定F-PSA/T-PSA对鉴别前列腺癌与前列腺增生的意义[J].大连医科大学学报,2005,27(1):54-56. 被引量:4
  • 3陈国军,陆建红,杨勇,董长林.血清T-PSA、F/T诊断前列腺肿瘤及其阳性预警值研究[J].武警医学,2005,16(3):174-176. 被引量:3
  • 4Jemal A,Siegel R,Ward E,et al.Cancer statistics2008[J].CA Cancer J Clin,2008,58(2):71-96.
  • 5Thompson IM,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level 4.0ng per milliliter[J].N Engl J Med,2004,350:2239-2246.
  • 6Jemal A,Thomas A,Murray T,et al.Cancer statistics[J].CA Cancer J Clin,2002,52 (1):23-47.
  • 7Leman ES,Getzenberg RH.Nuclear Structure as a Source of Cancer Specific Biomarkers[J].J Cell Biochem,2007,104(6):1988-1992.
  • 8Dhir R,Vietmeier B,Arlotti J,et al.Early identification of individuals with prostate cancer in negative biopsies[J].J Urol,2004,171 (4):1419-1423.
  • 9Paul B,Dhir R,Landsittel D,et al.Detection of prostate cancer with a blood-based assay for early prostate cancer antigen[J].Cancer Res,2005,65(10):4097-4100.
  • 10Dhir R, Vietmeier B, Arlotti J, et al. Early identification of indi- viduals with prostate cancer in negative biopsies[J]. J Urol, 2004, 171(4) 1419-1423.

共引文献23

同被引文献34

  • 1Bednarek AK, Laf lin KJ, Daniel RL, et al. WWOX, a novel WW- domain - containing p rote in mapping to human chromo- some16q23.3 -24,1, a region frequent ly affect ed in breast cancer [J]. Cancer Res,2000, 60 (8) :2140 -2145.
  • 2Otha M, Inoue H, Cott icelli MG, et al. The FHIT gene, spanning the chromosome 3p 14,2 fragile site and renal carcinoma - asociated t (3 ;8 )b reakpoint, is abnormal in digest ive t tact cancers[ J ]. Cell, 1996,84 (4) :587-597.
  • 3Zaw aeka - Pankau J, Ferens B. Enlightened protein : Fhit tumor- suppressor protein structure and function and it s role in the toxicity of protoporphyrin IX - mediated photodynamie reaction [ J ]. Toxicol Appl Pharmaeo1,2009,241 (2) :246 - 252.
  • 4Bureke L, Khan MA, Freemann AN , et al. Allelie deleti on analysis of the FHIT gene predicts poor survival in non small cell lung cancer [J].CaneerRes, 1998, 58(12) :2533 -2536.
  • 5Cantor JP, Liopoulos SD, Rao AS ,et al. Eplgenetlemodulatlon of en- dogenous tumor suppressor expression in lung cancer xenograf ts sup- presses tumori geni city [ J ]. Int J Cancer,2007,120 ( 1 ) : 24 - 31.
  • 6Chang NS, Hsu LJ, Lin YS, et al. Oxidoreduet ase : A candidat etumor suppressor[ J]. T rends Mol Med,2007,13 ( 1 ) : 12 - 22.
  • 7周水根,孙颖浩,高建平.DNA甲基化与前列腺癌[J].中华男科学杂志,2007,13(12):1108-1112. 被引量:6
  • 8Luco RF,Allo M,Schor IE,et al.Epigenetics in alternative premRNAsplicing[J].Cell,2011,144(1):16-26.
  • 9He Y,Cui Y,Wang W,et al.Hypomethylation of the hs-miR-191locus causes high expression of has-mir-191,and promotes the epithelial-to-mesenchymd transition in hepatocellular carcinoma[J].Neoplasia,2011,13:841-853.
  • 10Li Z,Xie J,Li W,et al.Identification and characterization of human PCDH10 gene promoter[J].Gene,2011,475(1):49-56.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部